| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007843739 |
| P356 | DOI | 10.1007/S11883-001-0065-0 |
| P698 | PubMed publication ID | 11286644 |
| P2093 | author name string | Moulton KS | |
| P2860 | cites work | Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 | Q24323317 |
| Thalidomide is an inhibitor of angiogenesis | Q24563363 | ||
| Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization | Q28280017 | ||
| Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators | Q28281001 | ||
| Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque | Q71707035 | ||
| Extravasated erythrocytes, iron, and fibrin in atherosclerotic plaques of coronary arteries in fatal coronary heart disease and their relation to luminal thrombus: frequency and significance in 57 necropsy patients and in 2958 five mm segments of 22 | Q71721869 | ||
| Cell turnover of capillaries | Q72352978 | ||
| Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
| Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial | Q73142282 | ||
| Aspirin for cancer | Q73226121 | ||
| Coronary risk factors and plaque morphology in men with coronary disease who died suddenly | Q73254792 | ||
| Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys | Q74314793 | ||
| Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia | Q74427018 | ||
| Intimal vascularization and atherosclerosis | Q75773697 | ||
| Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb | Q77531923 | ||
| Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis | Q77554947 | ||
| Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. | Q30636655 | ||
| Age-dependent impairment of angiogenesis | Q31936271 | ||
| Mouse model of angiogenesis | Q32061166 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages | Q33908328 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins | Q34479986 | ||
| Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. | Q34733220 | ||
| Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. | Q35764395 | ||
| Immunohistochemical study of intimal microvessels in coronary atherosclerosis | Q35832859 | ||
| Angiogenesis in human coronary atherosclerotic plaques | Q35833812 | ||
| Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb | Q37376876 | ||
| Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. | Q37380464 | ||
| Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro | Q37610426 | ||
| Nature of the stimulus leading to lymphocyte-induced angiogenesis | Q39257850 | ||
| Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease | Q39462155 | ||
| Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina | Q39817564 | ||
| Coronary Plaque Disruption | Q40459835 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Circulating endothelial precursors: mystery, reality, and promise | Q40741679 | ||
| Angiopoietin-1 protects the adult vasculature against plasma leakage. | Q40890338 | ||
| Angiogenesis in ischemic heart disease | Q41338703 | ||
| Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis | Q41543829 | ||
| Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing | Q41705080 | ||
| Possible background mechanisms of the effectiveness of cyclooxygenase-2 inhibitors in the treatment of rheumatoid arthritis | Q42538009 | ||
| Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content | Q42578006 | ||
| Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia | Q45886388 | ||
| Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia | Q45890406 | ||
| A Lamellar Unit of Aortic Medial Structure and Function in Mammals | Q47714030 | ||
| Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. | Q47924135 | ||
| Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls | Q48749029 | ||
| Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. | Q50517227 | ||
| Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. | Q50910091 | ||
| Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. | Q53905625 | ||
| Formation of new coronary arteries within a previously obstructed epicardial coronary artery (intraarterial arteries): a mechanism for occurrence of angiographically normal coronary arteries after healing of acute myocardial infarction. | Q53906018 | ||
| Activated macrophages induce vascular proliferation | Q53988557 | ||
| Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. | Q55032942 | ||
| Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction | Q56775151 | ||
| The human carotid atherosclerotic plaque stimulates angiogenesis on the chick chorioallantoic membrane | Q67539835 | ||
| Vasa vasorum in atherosclerotic coronary arteries: responses to vasoactive stimuli and regression of atherosclerosis | Q68266596 | ||
| Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction | Q68602033 | ||
| Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine | Q68704008 | ||
| Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content | Q71102869 | ||
| Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage | Q71473176 | ||
| Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance | Q71686477 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 225-233 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
| P1476 | title | Plaque angiogenesis and atherosclerosis | |
| P478 | volume | 3 |
| Q36336344 | 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. |
| Q30433214 | A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. |
| Q36742493 | ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response |
| Q42115221 | Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes |
| Q35581842 | Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease |
| Q46669142 | Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension |
| Q37668312 | Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis |
| Q30457409 | Assessment of atherosclerotic plaques in the rabbit abdominal aorta with interleukin-8 monoclonal antibody-targeted ultrasound microbubbles |
| Q34389842 | Assessment of neovascularization within carotid plaques in patients with ischemic stroke |
| Q24298258 | Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo |
| Q58246532 | Chemokines and atherosclerosis |
| Q37634390 | Contrast enhanced ultrasound imaging |
| Q37641072 | Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention |
| Q34967612 | Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice |
| Q44414098 | Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor |
| Q35077214 | Effects of statins on inflammation in patients with acute and chronic coronary syndromes |
| Q37115200 | Ethanolic extract of propolis inhibits atherosclerosis in ApoE-knockout mice |
| Q38067325 | Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography |
| Q26748661 | Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target |
| Q89657326 | Functional lncRNA-miRNA-mRNA networks in rabbit carotid atherosclerosis |
| Q58784996 | Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease |
| Q36535574 | Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins |
| Q80255835 | Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve |
| Q34400309 | Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis |
| Q35026501 | Microcirculation as a target for the anti-inflammatory properties of statins. |
| Q38300473 | Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth |
| Q37783547 | New Advances in Noninvasive Imaging of the Carotid Artery: CIMT, Contrast-Enhanced Ultrasound, and Vasa Vasorum |
| Q52650049 | Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis. |
| Q54219717 | Panax notoginseng saponins inhibits atherosclerotic plaque angiogenesis by down-regulating vascular endothelial growth factor and nicotinamide adenine dinucleotide phosphate oxidase subunit 4 expression. |
| Q92014120 | Plasma Placental Growth Factor Concentrations Are Elevated Well in Advance of Type 2 Diabetes Mellitus Onset: Prospective Data From the WHS |
| Q37789938 | Resident vascular progenitor cells |
| Q34136366 | Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. |
| Q58551068 | Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis |
| Q58569848 | Semaphorins and Their Receptors: From Axonal Guidance to Atherosclerosis |
| Q52886547 | Soluble fms-like tyrosine kinase-1 (sFLT-1) predicts post-percutaneous coronary intervention (PCI) myocardial infarction (MI type 4a). |
| Q35591461 | The association between statin use and age related maculopathy |
| Q35847328 | The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond |
| Q33267286 | The release of nitric oxide from S-nitrosothiols promotes angiogenesis |
| Q35160832 | The therapeuatic effect of Endostar on soft carotid plaque neovascularization in patients with non-small cell lung cancer |
| Q35542584 | Towards understanding acute destabilization of vulnerable atherosclerotic plaques |
| Q34662158 | Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-/- mice |
| Q58765933 | Ultrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse Model |
| Q30432040 | VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model |
| Q24799326 | Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation |
| Q28486087 | Vascular calcifying progenitor cells possess bidirectional differentiation potentials |
| Q51718919 | Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease. |
| Q36052961 | Vulnerable plaque: definition, detection, treatment, and future implications |
Search more.